Mechano-sensory hair cells (HCs), housed in the inner ear cochlea, are critical for the perception of sound. In the mammalian cochlea, differentiation of HCs occurs in a striking basal-to-apical and medial-to-lateral gradient, which is thought to ensure correct patterning and proper function of the auditory sensory epithelium. Recent studies have revealed that Hedgehog signaling opposes HC differentiation and is critical for the establishment of the graded pattern of auditory HC differentiation. However, how Hedgehog signaling interferes with HC differentiation is unknown. Here, we provide evidence that in the murine cochlea, Hey1 and Hey2 control the spatiotemporal pattern of HC differentiation downstream of Hedgehog signaling. It has been recently shown that HEY1 and HEY2, two highly redundant HES-related transcriptional repressors, are highly expressed in supporting cell (SC) and HC progenitors (prosensory cells), but their prosensory function remained untested. Using a conditional double knock-out strategy, we demonstrate that prosensory cells form and proliferate properly in the absence of Hey1 and Hey2 but differentiate prematurely because of precocious upregulation of the pro-HC factor Atoh1. Moreover, we demonstrate that prosensory-specific expression of Hey1 and Hey2 and its subsequent graded downregulation is controlled by Hedgehog signaling in a largely FGFR-dependent manner. In summary, our study reveals a critical role for Hey1 and Hey2 in prosensory cell maintenance and identifies Hedgehog signaling as a novel upstream regulator of their prosensory function in the mammalian cochlea. The regulatory mechanism described here might be a broadly applied mechanism for controlling progenitor behavior in the central and peripheral nervous system.
Introduction
Auditory hair cells (HCs) and their surrounding supporting cells (SCs) derive from a common pool of postmitotic prosensory cells within the developing cochlear duct . Atoh1, which encodes for a basic helix-loop-helix (bHLH) transcriptional activator, is necessary for the generation of inner ear HCs (Bermingham et al., 1999) and is among the earliest known markers of auditory HCs (Chen et al., 2002b; Cai et al., 2013) . Unique to the mammalian cochlea, ATOH1-mediated HC differentiation follows a distinct basal-to-apical gradient, whereby HCs located near the cochlear base differentiate first and the most apically located HCs differentiate last. In addition to the steep basal-to-apical differentiation gradient, a less steep gradient exits, with medially located inner HCs (IHCs) differentiating before laterally located outer HCs (OHCs) (Sher, 1971; Chen et al., 2002b) . This unique pattern of differentiation is thought to ensure the precise arrangement of HCs, with one row of IHCs and three rows of OHCs spanning the length of the cochlear duct. Recent findings have shown that Hedgehog signaling negatively regulates ATOH1-mediated HC differentiation and is critical for the establishment of the basal-to-apical gradient of HC differentiation in the mammalian cochlea (Driver et al., 2008; Bok et al., 2013; Tateya et al., 2013) . However, how Hedgehog signaling exerts its negative influence on Atoh1 expression and subsequently HC differentiation is unresolved. HES and HES-related HEY factors, which belong to the subfamily of bHLH transcriptional repressors, are known to interfere with bHLH activators at the transcriptional and post-transcriptional levels (Fischer and Gessler, 2007; Kageyama et al., 2008) . In the CNS, gain-offunction studies have suggested that HEY and HES proteins cooperate with each other in suppressing bHLH activator-driven neuronal differentiation and in maintaining the neural stem cell fate (Ishibashi et al., 1994; Sakamoto et al., 2003) . In the developing cochlea, two highly redundant Hey genes, Hey1 and Hey2, are highly expressed in prosensory cells but are rapidly downregulated upon their differentiation and only persist in a subset of SC precursors (Hayashi et al., 2008b; Li et al., 2008; Doetzlhofer et al., 2009) . In SC precursors, HEY1 and HEY2 cooperate with the coexpressed HES factors, HES1 and HES5, to repress a HCspecific gene program Tateya et al., 2011) . Their functions in prosensory cells are unknown, but based on their responsiveness to Notch signaling, it has been proposed that Hey1 and Hey2 function as Notch effectors in prosensory cell specification (Hayashi et al., 2008b) . However, more recent findings suggest that in prosensory cells Hey1 and Hey2 expression is controlled by additional unidentified Notch-independent signaling mechanisms (Basch et al., 2011) . Here, we show that Hey1 and Hey2 are dispensable for prosensory cell specification and proliferation but are critical for maintaining prosensory cells undifferentiated. Moreover, we identify Hedgehog signaling as a critical upstream regulator of their prosensory-specific expression and graded downregulation during cochlear differentiation. Together, our findings indicate that Hey1 and Hey2 control the spatial and temporal pattern of auditory HC differentiation downstream of Hedgehog signaling.
Materials and Methods
Mouse breeding and genotyping. Atoh1/nGFP transgenic mice (Lumpkin et al., 2003) were obtained from Jane Johnson (University of Texas Southwestern Medical Center, Dallas). Hey1 floxed (Fischer et al., 2005) and Hey2 knock-out (Gessler et al., 2002) 
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Ϫ/ϩ ) littermates were used as experimental controls. Atoh1 floxed and Pax2-Cre tg/ϩ mice were used to generate Atoh1 mutant mice (Pax2-Cre tg/ϩ; Atoh1 fl/fl ), designated Atoh1 ⌬/⌬ . These mice were maintained on a C57BL/6; CD-1 mixed background. Mice of both sexes were used in this study. Embryonic development was considered as E0.5 on the day a mating plug was observed. The day of birth was considered P0. All experiments and procedures were approved by the Johns Hopkins University Institutional Animal Care and Use Committees protocol, and all experiments and procedures adhere to National Institutes of Healthapproved standards.
Tissue harvest and processing. Embryos and early postnatal pups were staged using the EMAP eMouse Atlas Project (http://www.emouseatlas. org) Theiler staging criteria. Inner ear cochleae were collected in Hanks buffer (Invitrogen). To free the cochlear epithelial duct from surrounding tissue, dispase (1 mg/ml; Invitrogen) and collagenase (1 mg/ml; Worthington) mediated digest was used as previously described (Doetzlhofer et al., 2009) . To prevent overdigestion, tissue was refixed after enzyme digestion with 4% para-formaldehyde (PFA). To expose the auditory sensory epithelium (Stage P0 -P4), the cochlear capsule, spiral ganglion, and Reissner's membrane were removed, and the remaining tissue (cochlear surface preparation) was briefly fixed in 4% PFA. To obtain cochlear sections, whole heads (Stage E13.5-E15.5) or isolated inner ears (Stage P0-P4) were fixed in 4% PFA in PBS, cryoprotected using 30% sucrose in PBS, and embedded in OCT (Sakura Finetek) for cryosectioning.
Histochemistry and in situ hybridization (ISH) . Immunostaining was performed as described previously (Doetzlhofer et al., 2009) . Primary antibodies used were anti-Myosin VI (1:500, Proteus), anti-SOX2 (1:500, Santa Cruz Biotechnology), and anti-p75 (1:1000, EMD Millipore). Cell nuclei were fluorescently labeled with Hoechst-33258 dye (Sigma). Actin filaments were labeled with AlexaFluor (488 or 546) conjugated phalloidin (1:1000, Invitrogen). AlexaFluor (488 or 546) labeled secondary antibodies (1:1000, Invitrogen) were used. For ISH, pBluescript II (Stratagene) and pGem-T easy (Promega) vectors containing full-length mouse Atoh1, Sox2, Hey1, and Hey2 cDNA were used as templates to synthesize digoxigenin-labeled antisense RNA probes according to the manufacturer's specifications (Roche). The ISH procedure was modified from a protocol from Domingos Henrique (Henrique et al., 1995) .
Organotypic cochlear culture. E13.0-E13.5 embryos were screened for Atoh1/nGFP expression and staged (see Tissue harvest and processing). Embryos of inappropriate stage and nontransgenic embryos were discarded. Atoh1/nGFP transgenic inner ear cochleae were harvested in Hanks media (Invitrogen), and collagenase/dispase enzyme digest was used to free the cochlear duct from the surrounding mesenchyme. Remaining tissue, including the cochlear epithelial duct, the vestibular sacculus, and the innervating spiral ganglion, was placed onto filter membranes (SPI Supplies, Structure Probe) and cultured in DMEM-12 (Invitrogen), 1% FBS (Atlanta Biologicals), 5 ng/ml EGF (Sigma), 100 U/ml penicillin-streptomycin (Sigma), and 1ϫ B27 supplement (Invitrogen) . All cultures were maintained in a 5% CO 2 / 20% O 2 humidified incubator. Hedgehog ligand SHH (R&D Systems) was used at 50 nM final concentration. Hedgehog inhibitor cyclopamine-KAAD (EMD Millipore) was used at 5 M final concentration. FGFR inhibitor SU5402 (3-[(3-(2-carboxyethyl)-4-methylpyrrol-2-yl) methylene]-2-indolinone, Tocris Bioscience) was used at 10 M final concentration. Stock solutions for SHH (5 M in PBS 0.1% BSA), SU5402 (10 mM in DMSO), and cyclopamine-KAAD (5 mM in DMSO) were stored at Ϫ80°C. SHH, cyclopamine-KAAD, and SU5402 were added at plating, and control explants received 0.1% DMSO as vehicle control.
X-gal assay. To preserve LacZ encoded ␤-galactosidase activity,
LacZ/ϩ cochlear explant cultures were fixed for 10 min with 2% PFA on ice. After washing in PBS, tissue was incubated at 35°C overnight in X-gal reaction buffer containing 1 mg/ml X-gal (5-bromo-4-chloro-3-indolyl-b-Dgalactopyranoside, Corning, Cellgro), 5 mM K 3 Fe(CN) 6 (Sigma), 5 mM K 4 Fe(CN) 6 (Sigma), and 2 mM MgCl 2. (Sigma) in PBS.
RNA extraction and qPCR. Before RNA extraction, cochlear epithelia were isolated from cultured cochlear explants using dispase/collagenase treatment, and three to four cochlear epithelia were pooled per condition. RNeasy Micro kit (QIAGEN) was used to isolate total RNA, and mRNA was transcribed into cDNA using iScript kit (Bio-Rad). qPCR was performed with a SYBR Green kit (Invitrogen) and gene-specific primer sets on a StepOne Plus PCR Detection System (Applied Biosystems/ Invitrogen). Each PCR was performed in triplicate. Relative gene expression was analyzed by using the ⌬⌬CT method (Schmittgen and Livak, 2008) . The comparative Ct study feature of StepOne plus software (Applied Biosystems/Invitrogen) was used to aggregate biological replicate data. C-DNA from freshly isolated cochlear epithelia, Stage E15.5 was used as a calibrator, and the ribosomal gene Rpl19 was used as endogenous reference gene. The following primers were used for qPCR: Atoh1 forward, ATG CAC GGG CTG AAC CA; Atoh1-R TCG TTG TTG AAG GAC GGG ATA; Sox2 forward, CTG TTT TTT CAT CCC AAT TGC A; Sox2 reverse, CGG AGA TCT GGC GGA GAA TA; Hey1 forward, CAC TGC AGG AGG GAA AGG TTA T; Hey1 reverse, CCC CAA ACT CCG ATA GTC CAT; Hey2 forward, AAG CGC CCT TGT GAG GAA A; Hey2 reverse, TCG CTC CCC ACG TCG AT; Hes1 forward, GCT TCA GCG AGT GCA TGA AC; Hes1 reverse, CGG TGT TAA CGC CCT CAC A; Fgf20 forward, CAC GGG TCG CAG GTA TTT TG; Fgf20 reverse, CCT GGC ACC ATC TCT TGG A; Isl1 forward, CGG AGA GAC ATG ATG GTG GTT; Isl1 reverse, AGG GCG GCT GGT AAC TTT G; Id1 forward, GAA CGT CCT GCT CTA CGA CAT G; Id1 reverse, TGG GCA CCA GCT CCT TGA; Id2 forward, AAG GTG ACC AAG ATG GAA ATC CT; Id2 reverse, CGA TCT GCA GGT CCA AGA TGT; Id3 forward, GAG CTC ACT CCG GAA CTT GTG; Id3 reverse, CGG GTC AGT GGC AAA AGC; Ptch1 forward, CTG GCT CTG ATG ACC GTT GA; Ptch1 reverse, GCA CTC AGC TTG ATC CCA ATG; Rpl19 forward, GGTCTGGTTG-GATCCCAATG; Rpl19 reverse, CCCGGGAATGGACAGTCA.
Proliferation assay. EdU (5-ethynyl-2Ј-deoxyuridine, Invitrogen) was reconstituted in PBS and administered at 50 g per gram of body weight to time-mated pregnant dams by a single intraperitoneal injection. Click-iT AlexaFluor-488 or -546 Kit (Invitrogen) was used to detect incorporated EdU according to the manufacturer's specifications. EdU incorporation in prosensory cells, HCs, and SCs was quantified in co-chlear sections and cochlear surface preparations, which have been stained with a nuclear dye (Hoechst-33258) and immunostained for SOX2 and myosin VI (MYO6) to visualize prosensory cells, SCs, and HCs, respectively. Confocal images were assembled and analyzed in Photoshop CS3 (Adobe), and ImageJ software (National Institutes of Health) was used to measure the length of counted segments.
Quantification of basal to apical extent of HC differentiation. HC differentiation in E13.0 -E13.5 Atoh1/nGFP transgenic cochlear explants was monitored over 48-h culture period, and green fluorescent images of native GFP expression were captured using fluorescent stereo-microscopy (Leica) every 12 h. HC differentiation in E15.0 DKO and control cochlear tissue was analyzed in enzyme-purified cochlear epithelial preparations immunostained for HC marker MYO6. Fluorescent images were analyzed in Photoshop CS3 (Adobe), and lengths of Atoh1/nGFP-positive and MYO6-positive domains were measured using ImageJ software (National Institutes of Health).
Quantification of HCs and SCs. Cochlear surface preparations obtained from P0 -P2 DKO (Hey1 ⌬/⌬ Hey2 Ϫ/ Ϫ ) pups and control littermates (Hey2 Ϫ/ϩ and Hey2 Ϫ/ Ϫ ) were immunostained for MYO6 and SOX2. High-power confocal images of SC layer (SOX2 ϩ ) and HC layer (MYO6 ϩ ) at defined apical-basal positions were used for HC and SC counts. Low-power fluorescent images of the HC layer were used to reconstruct the entire cochlear sensory epithelium. Images were assembled and analyzed in Photoshop CS3 (Adobe). ImageJ software (National Institutes of Health) was used to measure length of counted segments and total length.
Statistical analysis. Values are presented as mean Ϯ SEM; n ϭ biological replicates analyzed. Two-tailed Student's t tests were used to determine the confidence interval. p Յ 0.05 were considered significant. p values Ͼ 0.05 were considered not significant.
Results

Downregulation of Hey1 and Hey2 during cochlear differentiation occurs independently of Atoh1
Hey1 and Hey2 are highly expressed by prosensory cells in the undifferentiated cochlea. As differentiation progresses along the developing cochlear duct, their expression becomes restricted to distinct subtypes of SCs (Hayashi et al., 2008b; Li et al., 2008; Doetzlhofer et al., 2009 ). The mechanism responsible for the graded downregulation of Hey1 and Hey2 during cochlear differentiation is currently unknown. One possibility is that Hey1 and Hey2 downregulation is a result of HC differentiation. To examine the dynamics of Hey1 and Hey2 expression in prosensory cells and to address whether Hey1 and Hey2 downregulation depends on HC differentiation, Hey1, Hey2, and Atoh1 mRNA expression was analyzed in embryonic day 13.5 (E13.5) and E15.5 wild-type and E15.5 Atoh1 mutant cochlear tissue using RNA in situ hybridization (ISH) assays. ISH staining for Sox2 was used to mark the prosensory/sensory domain (bracket). Sox2 encodes for a high-mobility group transcription factor, known to be highly expressed in prosensory cells and embryonic HCs and SCs (Kiernan et al., 2005) . At E13.5, Hey1 and Hey2 were coexpressed with Sox2 in prosensory cells throughout the cochlear duct ( Fig.  1 A, C,D, bracket), whereas Atoh1 was beginning to be upregulated in prosensory cells at the base of the cochlea (Fig. 1B , bracket). 48 h later, at E15.5, Atoh1 was highly expressed in both IHCs (arrowhead) and OHCs (bar) in the cochlear base. In the cochlear mid-turn Atoh1 was highly expressed in IHCs and was beginning to be upregulated in future OHCs (Fig. 1F , arrowhead and bar). In the undifferentiated cochlear apex, Atoh1 was faintly expressed in future IHCs at the medial border of the prosensory domain (Fig. 1F , arrowhead, bracket). At E15.5, Hey1 and Hey2 were highly expressed in the Sox2-positive prosensory domain in the undifferentiated cochlear apex, but in the cochlear mid-turn Hey1 and Hey2 expression domain narrowed to the undifferentiated OHC domain (Fig. 1 E, G,H ). In the cochlear base, which already contained Atoh1 expressing IHCs and OHCs, Hey1 and Hey2 expression was confined to differentiating SC precursors ( Fig. 1F-H ) . Previous studies showed that in the Atoh1 mutant cochlea, prosensory cells form and express Sox2 and Hey2 but fail to differentiate into HCs and SCs (Woods et al., 2004; Kiernan et al., 2005; Li et al., 2008) . Consistent with these findings, prosensory-specific expression of Sox2, Hey1, and Hey2 in the undifferentiated cochlear apex appeared to be unaffected by the loss of Atoh1 (Fig. 1I-L) . Moreover, the initial downregulation of Hey1 and Hey2 appeared to be equally unaffected by the loss of Atoh1. In the mid-turn of both the E15.5 wild-type (Fig. 1G ,H ) and Atoh1 mutant ( Fig. 1 K, L ) cochleae, Hey1 (Fig. 1G,K ) and Hey2 ( Fig. 1 H, L) were downregulated in the IHC domain but continued to be weakly expressed in the OHC domain. However, in the Atoh1 mutant cochlear base, no Sox2, Hey1, or Hey2 expression was detected ( Fig. 1 I, K,L) . Previous studies showed that basally located prosensory cells in the Atoh1 mutant cochlea start to undergo apoptosis at E15.5 (Chen et al., 2002b; Cai et al., 2013) . The observed loss of Sox2, Hey1, and Hey2 expression in the base of the Atoh1 mutant cochlea is likely to be a secondary effect caused by the death of HC and SC precursors. Together, our data demonstrate that the initial downregulation of Hey1 and Hey2 in prosensory cells occurs independently of Atoh1, suggesting that Hey1 and Hey2 might act upstream of Atoh1 and might negatively regulate Atoh1 induction during cochlear differentiation.
Loss of Hey1 and Hey2 results in premature onset of HC differentiation
To determine the function of Hey1 and Hey2 in the developing cochlea, Hey1-Hey2 double mutant animals were generated. Conventional Hey1-Hey2 double-mutant animals die during early embryonic development because of severe vascular defects (Fischer et al., 2004) . To prevent early embryonic lethality, a conditional knock-out strategy was applied in which, in a Hey2 mutant background (Gessler et al., 2002) , Hey1 floxed allele (Fischer et al., 2005) was ablated using the inner ear-specific Pax2-Cre line (Ohyama and Groves, 2004) . As previously reported, Hey1 single knock-out mice show no obvious changes in both the number and organization of HCs or SCs (Hayashi et al., 2008b; Doetzlhofer et al., 2009 ). Hey2 single knock-out mice have, dependent on their strain background, either no defects in the number or organization of HCs or SCs (Hayashi et al., 2008b) or only very mild HC and SC patterning defects Doetzlhofer et al., 2009 ). Moreover, a previous study revealed no defects in prosensory cell proliferation or differentiation, allowing the use of Hey2 single mutants as experimental controls . To confirm conditional Hey1 deletion, qPCR experiments were performed on enzyme-purified cochlear epithelial ducts at Stage ϳE13.5. Our analysis revealed that Hey1 as well as Hey2 mRNA expression in the DKO cochlear epithelia was reduced 10-fold compared with cochlear epithelia obtained from control littermates with one intact allele of Hey1 or Hey2, respectively. This suggests that our strategy successfully ablated Hey1 and Hey2 in the developing cochlea ( Fig. 2A, red and white bar) . Furthermore, our analysis revealed no significant difference in Sox2 mRNA expression in DKO cochlear epithelia compared with control epithelia (Hey1 Fig. 2A , gray bar), suggesting that prosensory cell formation was not impacted by the loss of Hey1 and Hey2. However, we observed that Atoh1 was noticeably higher expressed in DKO cochlear epithelia, compared with cochlear epithelia obtained from control littermates (Fig. 2A , dark gray bar). To address whether HC differentiation might have occurred prematurely in the absence of Hey1 and Hey2, the pattern of Atoh1 transcript, ATOH1 activity, and HC-specific marker expression was analyzed in DKO embryos and their littermate controls ranging in stages from E14.0 to E15.5. At E14.5 in Hey2 Ϫ/ Ϫ control littermates, Atoh1 mRNA was only expressed in the cochlear base in a narrow band of cells, which will give rise to IHCs (Fig. 2B) . However, in DKO embryos, Atoh1 mRNA was readily detected in both the IHC and OHC domains in the cochlear base and in the future IHC domain in the mid-turn of the cochlear duct (Fig. 2C) . At E15.0 in control littermates, Atoh1 mRNA was expressed in both IHCs (arrowhead) and OHCs (bar) in the cochlear base and in IHCs in the cochlear mid-turn, but no Atoh1 expression was detected in the cochlear apex (Fig. 2D) . However, in DKO animals, Atoh1 was readily detected in IHCs and OHCs 
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Ϫ/ Ϫ (DKO) and Hey2 Ϫ/ϩ and Hey2 Ϫ/Ϫ (control) littermates. Graphs represent cochlear duct length (J ) and length of MYO6-positive sensory domain (K ) for control (gray bar) and DKO (red bar) cochlear ducts. Data are mean Ϯ SEM. n ϭ 4 or 5 cochlear explants from three independent experiments. *p Յ 0.05. n.s., Not significant. both in the cochlear base and cochlear mid-turn and Atoh1 mRNA started to be upregulated in the cochlear apex (Fig. 2E) . To determine whether ATOH1 activity was also prematurely upregulated in the absence of Hey1 and Hey2, we crossed the wellcharacterized HC-specific Atoh1/nGFP transgenic line into our Hey1-Hey2 double mutant line. Previous studies demonstrated that the Atoh1 enhancer used to drive GFP reporter expression is positively regulated by ATOH1 itself, making Atoh1/nGFP transgene expression a readout for ATOH1 activity (Helms et al., 2000; Lumpkin et al., 2003) . At E13.5-E14.0, HC differentiation initiates at the cochlear mid-base, and in E14.0 Hey2 Ϫ/ Ϫ littermates (control) a narrow band of GFP-positive cells was only present in the cochlear base, representing future IHCs (Fig. 2 F, FЈ) . No GFP-positive cells were observed further apically in the cochlear mid-turn (Fig. 2 F, FЉ) . However, in E14.0 DKO embryos, GFP was broadly expressed in future IHC and OHCs in the cochlear base (Fig. 2G,GЈ) , and GFP-positive cells were already observed in the cochlear mid-turn (Fig. 2G,GЉ) . To quantify the basal-toapical extent of HC differentiation, cochlear epithelial preparations of Stage E15.0 DKO (Fig. 2I ) and their Hey2 Ϫ/ Ϫ control littermates (Fig. 2H ) were stained with the HC marker myosin VI (MYO6), and the length of the sensory domain containing MYO6-positive HCs was measured. As expected, both DKO and control cochlear epithelia were similar in length (Fig. 2J ) ; however, HC differentiation, as judged by the basal-to-apical extent of HC-specific MYO6 expression, was more advanced in the Hey1-Hey2 double mutant (DKO) cochlea than in the Hey2 single mutant cochlea (control) (Fig. 2K ) . In summary, our data suggest that Hey1 and Hey2 are critical for preventing premature upregulation of Atoh1 in prosensory cells and loss of Hey1 and Hey2 results in premature HC differentiation along the developing cochlear duct.
Loss of Hey1 and Hey2 results in abnormal distribution of OHCs along the cochlear duct
To determine how loss of Hey1 and Hey2 might impact HC patterning, cochlear surface preparations and cochlear sections were prepared from neonatal Hey1 ⌬/⌬ Hey2 Ϫ/ Ϫ (DKO) pups and Hey2 Ϫ/ Ϫ and Hey2 Ϫ/ϩ littermate controls and stained for HC markers. Immunostaining for MYO6 was used to visualize HC soma, and phalloidin staining was used to visualize the HCspecific actin-rich apical protrusions called stereocilia. It has previously been shown that, in Hes/Hey compound mutants, in which either Hey1 or Hey2 were codeleted with Hes1 and or Hes5, HC density and ectopic HCs are significantly increased compared with control tissue Tateya et al., 2011) . Surprisingly, in Hey1-Hey2 double mutants (DKO), HC density as well as the total length of the sensory epithelium (52.8 Ϯ 2.7 HCs/100 m, 6083.8 Ϯ 117.6 m, n ϭ 6) was not significantly different from Hey2 Ϫ/ϩ (48.6 Ϯ 1.2 HCs/ 100 m, 6206.8 Ϯ 89.8 m, n ϭ 5) and Hey2 Ϫ/ Ϫ (51.8 Ϯ 0.6 HCs/100 m, 5863.7 Ϯ 178.2 m, n ϭ 5) littermate controls, indicating that HCs were not overproduced in the absence of Hey1 and Hey2. However, the precise cellular pattern of one row of IHCs and three rows of OHCs seen throughout the length of the auditory sensory epithelium in Hey2 single mutant (control) neonatal pups (Fig. 3 A, C,E) was significantly altered in Hey1-Hey2 double mutant (DKO) pups (Fig.  3 B, D,F ) . In the absence of Hey1 and Hey2, ectopic IHCs were most frequently observed in the cochlear mid-turn (Fig. 3 D, I ), whereas ectopic OHCs were most frequently observed in the cochlear base (Fig. 3 F, J ) . Strikingly, in DKO cochleae, OHCs were frequently missing in the cochlear apex, and the sensory epithelium consisted only of two rows of OHCs instead of three (Fig.   3 B, K ) . Moreover, mispatterned HCs in DKO cochleae frequently had deformed and misoriented stereocilia (Fig. 3 B, D,F ) . In mice, patterning of auditory HCs as well as stereocilia orientation is not fully completed at birth, and both processes undergo refinement in the first postnatal days (Anniko, 1983) . To determine whether the defects persist until later stages of postnatal refinement, we analyzed the HC patterning and stereocilia orientation in postnatal day 4 (P4) Hey2 Ϫ/ Ϫ (Fig. 3G) and DKO cochlear tissue (Fig. 3H ) . Our examination revealed that both HC patterning defects and stereocilia defects were largely retained as exemplified by the OHC patterning defects and stereocilia defect seen in the cochlear apex of DKO pups at P4 (Fig. 3H ) . Next, we examined the SC phenotype in the Hey1-Hey2 double mutant cochlea (DKO). SOX2 immunostaining was used to mark all subtypes of SCs. Moreover, SC subtypes were further subdivided into inner SCs (inner border cells, inner phalangeal cells) and outer SCs (pillar cells and Deiters cells) based on nuclear morphology and relative position within the sensory epithelium. Outer SC (oSC) density and total length of the sensory epithelium were not significantly changed in neonatal DKO pups (68.4 Ϯ 1.2 oSCs/ 100 m, 5945 Ϯ 298 m, n ϭ 3) compared with Hey2 Ϫ/ϩ (65.7 Ϯ 1.0 oSCs/100 m, 6170.58 Ϯ 212 m, n ϭ 3) and Hey2 Ϫ/ Ϫ (70.9 Ϯ 2.1 oSCs/100 m, 5706.5 Ϯ 145.5 m, n ϭ 3) littermate controls, suggesting that the oSCs were not overproduced in the absence of Hey1 and Hey2. However, oSCs were similar to OHCs unevenly distributed along the Hey1-Hey2 double mutant cochlear duct, with ectopic oSCs in the cochlear base (Fig. 3O ,OЈ,U, white and yellow arrows) and missing oSCs in the cochlear apex (Fig. 3 M, MЈ ,Q, white and yellow dashed line). Moreover, the occasional ectopic IHCs were accompanied by ectopic inner SCs (iSCs) as exemplified by supernumerary SOX2-positive iSCs in the cochlear mid-turn (Fig. 3S, white and yellow asterisk) . In addition, we found evidence for late SC-to-HC conversion in DKO cochlea. In the late embryonic and early postnatal cochlea, Hey1 and Hey2 are coexpressed in outer pillar cells, suggesting a role in the differentiation or maintenance of outer pillar cells. To analyze the outer pillar cell phenotype, p75 immunostaining was used. In the early postnatal cochlea, the low-affinity neurotrophin receptor p75 (NGFR) is highly expressed on the apical surface of both outer and inner pillar cells (von Bartheld et al., 1991) . Similar to Hey2 Ϫ/ϩ control tissue, in DKO cochlear surface preparations, p75-positive cells were clearly present in the in the pillar cell region, suggesting that pillar cells differentiate normally in the absence of Hey1 and Hey2 (Fig. 3V-WЈ) . However, we observed occasional gaps in the p75-positive stripe, in which p75-positive pillar cells were replaced by HCs, suggesting a late pillar cell-to-HC fate switch in the absence of Hey1 and Hey2 (Fig.  3W ,WЈ, white asterisk). In summary, our analysis revealed that, in the absence of Hey1 and Hey2, the normal cellular pattern of the auditory sensory epithelium is severely disrupted. Some of the patterning defects, such as the frequently observed ectopic IHCs, are shared with Hes single and Hes/Hey compound mutants and are likely due to defects in partition of the prosensory cell pool into HCs and SCs. However, the uneven distribution of OHCs and oSCs along the cochlear duct and the ectopic HCs within the pillar cell region is unique to Hey1-Hey2 double mutants and is consistent with a function of Hey1 and Hey2 in prosensory cell maintenance and a later function in maintaining a pillar cell fate.
Loss of Hey1 and Hey2 does not alter the timing or pattern of prosensory cell cycle withdrawal
In the developing brain, HES and HEY transcription factors are critical for maintaining proliferation of neural stem cells and progenitor cells, and loss of Hes/Hey function results in premature cell cycle withdrawal (Sakamoto et al., 2003; Kageyama et al., 2008; Fujitani et al., 2010) . Similarly, in the developing cochlea, loss of Hes1, which is expressed at low levels at the prosensory stage, results in premature cell cycle withdrawal (Murata et al., 2009 ). In the murine cochlea, cell cycle exit of prosensory cells occurs within a 48 h time window and follows an apical-to-basal gradient, with apical progenitors exiting first ϳE12.5 and very basal progenitors exiting as late as E14.5 (Ruben, 1967; Lee et al., 2006) . To determine whether loss of Hey1 and Hey2 might have caused premature cell cycle withdrawal, the rate of prosensory cell proliferation was analyzed at E13.5, the peak of cell cycle withdrawal in Hey2 Ϫ/ Ϫ (control) and Hey1 ⌬/⌬ Hey2 Ϫ/ Ϫ (DKO) mice. Timedmated dams received a single injection of the thymidine analog EdU at E13.5 and EdU incorporation was analyzed 2 days later in cochlear sections using a chemical assay (Salic and Mitchison, 2008) . SOX2 immunostaining was used to mark prosensory cells and their progenies (HC and SC precursors). We reasoned that, if HEY1 and HEY2 positively regulate prosensory cell proliferation, loss of Hey1 and Hey2 should reduce the number of cycling SOX2-positive HC and SC precursors. However, an EdU pulse at E13.5 revealed no difference in overall proliferation, timing, or pattern of cell cycle withdrawal. SOX2-positive prosensory cells in control (Fig. 4 A, C,E) and DKO (Fig. 4 B, D,F ) animals incorporated EdU at similar rates, showing a similar pattern of apical-tobasal cell cycle withdrawal with very low EdU incorporation in the cochlear apex and highest incorporation in the cochlear base (Fig. 4G) . Next, we examined whether the onset of cell cycle withdrawal of HC and SC precursors occurs prematurely in the absence of Hey1 and Hey2. Timed-mated dams received a single injection of EdU at E12.5, and EdU incorporation in IHCs and OHCs and oSCs was analyzed in cochlear surface preparations of DKO animals and Hey2 Ϫ/ϩ and Hey1
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Ϫ/ϩ control littermates, Stage E18.5. In littermate controls, EdU incorporation in MYO6-positive IHCs and OHCs declined from base to apex with the lowest frequency of EdU incorporation in the most apical region (Fig. 4H-L , R, S, light and dark gray bar). Similarly, in the absence of Hey1 and Hey2, EdU incorporation in IHCs and OHCs gradually declined from base to apex, with the lowest frequency of EdU incorporation in the most apical region (Fig. 4M-Q, R, S, red bar) . Moreover, loss of Hey1 and Hey2 did not alter the spatiotemporal pattern of cell cycle withdrawal of SC precursors, as evidenced by the similar rate of EdU incorporation in control (Fig. 4T , light and dark gray bar) and DKO oSC precursors (Fig. 4T, red bar) . The only differences we noted were that Hey1-Hey2 double mutant IHCs located in the cochlear base incorporated EdU at lower levels than Hey2 Ϫ/ϩ control (Fig. 4R , red and light gray bar). The lower than normal EdU incorporation of basally located IHCs is likely to be a secondary effect due to forced cell cycle exit caused by their premature differentiation. In summary, our EdU incorporation data suggest that loss of Hey1 and Hey2 does not significantly alter the overall proliferation rate of prosensory cells or the apical-tobasal pattern of prosensory cell cycle withdrawal.
Hedgehog signaling maintains Hey1 and Hey2 expression in prosensory cells
Hey1 and Hey2 are well-characterized transcriptional targets of Notch signaling. However, the regulation of Hey1 and Hey2 expression in cochlear prosensory cells appears to be more complex, as loss of canonical Notch signaling has no effect on Hey1 and Hey2 mRNA expression in prosensory cells (Basch et al., 2011) . A candidate pathway for positively regulating Hey1 and Hey2 transcription at the prosensory stage is Hedgehog signaling. Ϫ/ Ϫ control (gray bar) and DKO (red bar) prosensory cells in the cochlear apex, mid, and base. Data are mean Ϯ SEM (n ϭ 3, two independent experiments). n.s., Not significant. H-T, Loss of Hey1 and Hey2 does not alter proliferation rate of HC and SC precursors. EdU was injected at E12.5 and EdU incorporation in HCs and SCs was analyzed at E18.5 in control (Hey2 Ϫ/ϩ and Hey1 ⌬/⌬ Hey2 Ϫ/ϩ ) and DKO cochlear surface preparations. H-Q, EdU incorporation in E18.5 Hey2 Ϫ/ϩ (control) (H-L) and DKO (M-Q) cochlear sensory epithelium. Shown are high-power confocal images of MYO6-positive HC layer (green) at the cochlear apical tip (H, M ), apex (I, N ), mid-apex (J, O), mid-base (K, P), and base (L, Q). Arrows point to IHCs; brackets indicate OHCs. EdU-positive nuclei are shown in red. Scale bar, 50 m. R-T, Quantification of EdU incorporation in IHCs (R), OHCs (S), and oSCs (T ) in E18.5 Hey2 Ϫ/ϩ (light gray), Hey1 ⌬/⌬ Hey2 Ϫ/ϩ (dark gray), and DKO (red). Data are mean Ϯ SEM (n ϭ 3, two independent experiments). *p Յ 0.05. n.s., Not significant.
Overactivation of Hedgehog signaling in the undifferentiated cochlea blocks Atoh1 induction and subsequently HC generation (Driver et al., 2008; Tateya et al., 2013) , and there is mounting evidence that a Hedgehog activity gradient controls the gradient of HC differentiation. Hedgehog signaling in prosensory cells is thought to be activated by the Hedgehog ligand SHH, which is transiently produced by spiral ganglion neurons during cochlear outgrowth (Driver et al., 2008; Liu et al., 2010) . Spiral ganglionspecific deletions of Shh result in severe to moderate cochlear outgrowth defects dependent on the time of ablation. In addition, deletion of Shh causes prosensory cells to drop out of the cell cycle prematurely and to differentiate precociously (Bok et al., 2013) . Similarly, the cochlear-specific genetic ablation of Smoothened (Smo), which encodes for a critical transduction component of Hedgehog signaling, results in precocious HC differentiation (Tateya et al., 2013) . To examine the relationship among Hedgehog signaling, Hey1 and Hey2 expression, and HC differentiation, we made use of a well-characterized cochlear explant system in which the developing cochlear epithelial duct and its innervating spiral ganglion are cultured in the presence of mesenchyme (Montcouquiol and Kelley, 2003; Doetzlhofer et al., 2009 ). Native nuclear GFP expression of the HC-specific Atoh1/nGFP line was used to monitor the dynamics of HC differentiation. Exogenous SHH protein was added to stimulate Hedgehog signaling, and cyclopamine, a steroidal alkaloid known to inhibit SMO (Chen et al., 2002a) , was added to inhibit Hedgehog signaling in Stage E13.5 cochlear tissue. At plating and after 12 h in vitro, untreated (control), SHH-treated, and cyclopamine-treated explants showed no HC-specific Atoh1/ nGFP expression in the developing cochlear duct (Fig. 5 A, D,G) . However, after 24 h in vitro, striking differences in the basal-toapical progression of HC differentiation emerged. In cochlear explants treated with cyclopamine, IHC differentiation was further progressed (Fig. 5 E, J ) than in untreated control cultures (Fig. 5 B, J ) . However, cochlear explants treated with exogenous SHH contained no or only few GFP-positive HCs after 24 h in vitro (Fig. 5 H, J ) . After 48 h in vitro, differences in the extent of OHC differentiation (medial-to-lateral gradient) emerged, with OHC differentiation being more advanced in cyclopaminetreated explants (Fig. 5C,F ) and less advanced in SHH-treated explants compared with control explants (Fig. 5C,I ). To determine whether Hey1 and Hey2 might be targets of Hedgehog signaling, we analyzed the transcript levels of Hey1 and Hey2 in enzyme-purified cochlear epithelia after 24 h of SHH-mediated Hedgehog overactivation (Fig. 5K ) or cyclopamine-mediated Hedgehog inhibition (Fig. 5L) . To confirm successful overactivation or inhibition of Hedgehog signaling in our experimental paradigm, we included in our qPCR analysis the known Hedgehog target gene Ptch1 (Patched homolog 1) (Vokes et al., 2007) . Our qPCR-based analysis revealed that Hey1, Hey2, and Ptch1 transcripts were significantly increased in SHH-treated cochlear explants compared with untreated control explants (Fig. 5K ) . Conversely, in the presence of Hedgehog inhibitor cyclopamine, Hey1, Hey2, and Ptch1 transcripts were significantly reduced compared with explants treated with vehicle control DMSO (Fig.  5L) . The modest but significant reduction of Hey1 transcript levels in cyclopamine-treated cultures suggests that Hedgehogindependent mechanisms might compensate for the loss of Hedgehog signaling. A significant increase in transcript levels in response to Hedgehog overactivation was also observed for Sox2, Hes1, and Fibroblast growth factor 20 (Fgf20) (Fig. 5K ). Similar to Hey1 and Hey2, Hes1, Sox2, and Fgf20 are positively regulated by Notch signaling in the developing cochlea (Takebayashi et al., 2007; Hayashi et al., 2008a, b) , suggesting cooperation between Notch and Hedgehog signaling in maintaining their expression in prosensory cells. We also examined the mRNA expression of the prosensory-specific HLH factors and known ATOH1 antagonists ID1, ID2, ID3, and the prosensory-specific transcription factor ISLET1 (ISL1) (RaddeGallwitz et al., 2004; Jones et al., 2006) . However, none of these transcripts showed Hedgehog dependency, suggesting that modulation of Hedgehog signaling does not globally alter progenitor-specific gene expression (Fig. 5 K, L) . To determine how Hedgehog signaling affects the spatial and temporal pattern of Hey2 expression, we made use of our Hey2 knock-out line, in which exon 2 of the Hey2 gene was knocked out by LacZ insertion (Hey2 LacZ/ϩ ) (Gessler et al., 2002) . E13.0 Atoh1n/GFP transgenic Hey2
LacZ/ϩ cochlear explants were cultured in the absence (control) or presence of exogenous SHH, and after 48 h in vitro Hey2-LacZ expression was analyzed using the X-gal assay ( Fig. 5M-NЈ ; X-gal). GFP expression marked HCs and IHCs (arrowhead) and OHCs (bar) were identified by their location within the sensory epithelium ( Fig. 5M-NЈ; GFP) . In control cochlear explants, broad Hey2 expression in the undifferentiated cochlear apex narrowed to the OHC domain in the cochlear mid-apex. In the differentiated cochlear mid-base and base, which already contained both IHCs and OHCs, Hey2 expression was limited to the pillar cell region (Fig. 5 M, MЈ) . However, in cochlear explants treated with exogenous SHH, Hey2 remained broadly expressed throughout most of the length of the cochlear duct, strongly correlating with the delayed upregulation of GFP in HCs (Fig. 5 N, NЈ) . Together, our analysis identifies Hey1 and Hey2 as targets and likely effector genes of Hedgehog signaling in the developing cochlea.
FGF signaling functions downstream of Hedgehog signaling in Hey1 and Hey2 regulation
A recent study has shown that forced expression of a constitutively active Smo allele (Smo-M2) results in prolonged Fgf20 expression in prosensory cells and a permanent block of OHC differentiation. Interestingly, interference with FGF20-activated FGFR signaling reverses the inhibitory effect of Hedgehog overactivation in E17.5 R26-Smo-M2 transgenic cochlear explants and restores OHC differentiation (Tateya et al., 2013) . We recently have shown that FGFR signaling cooperates with Notch signaling in the transcriptional regulation of Hey2 in pillar cells (Doetzlhofer et al., 2009) , and an intriguing scenario is that FGFR signaling might similarly contribute to the regulation of Hey2 in prosensory cells. To determine whether FGFR signaling is required for the positive effects of Hedgehog signaling on Hey1 and Hey2 expression, E13.5 Atoh1/nGFP transgenic cochlear explants were cultured in the presence of FGFR kinase inhibitor SU5402 (Mohammadi et al., 1997) , SHH and SU5402, SHH and DMSO, or DMSO for 24 h (Fig. 6A-H ) . Compared with vehicle control (DMSO), treatment with SU5402 did not alter the onset of HC differentiation (Fig. 6 A, B) , nor did it alter the rate at which HC differentiation progressed toward the cochlear apex (Fig. 6E,F,I ). However, cotreatment with SHH and FGFR inhibitor (SHH ϩ SU5402) reversed the inhibitory effect of Hedgehog overactivation (SHH ϩ DMSO) on HC differentiation (Fig. 6G-I ) . Next, we analyzed whether FGF signaling is required for Hedgehog mediated activation of Hey2 and or Hey1 transcription. Treatment of E13.5 cochlear explants with exogenous SHH (SHH ϩ DMSO) increased Fgf20, Hey2, and Ptch1 expression by Ͼ3-fold and increased Hey1 expression ϳ2-fold (Fig. 6J ) . However, cotreatment of cochlear explant cultures with SHH and FGFR inhibitor (SHH ϩ SU5402) largely reversed the positive effects of SHH treatment (SHH ϩ DMSO) on Hey2 and Hey1 expression (Fig. 6J ) . Importantly, cotreatment with SHH and SU5402 did not alter expression of the known Hedgehog target gene Ptch1, nor did it alter the expression of Fgf20, suggesting that cotreatment with SU5402 did not globally attenuate SHH-activated Hedgehog signaling. However, in contrast to cyclopamine treatment, which reduced both Hey1 and Hey2 levels (Fig. 5L) , SU5402 treatment did not reduce Hey1 and Hey2 mRNA levels compared with the control (Fig. 6J ). This could be in part due to incomplete inhibition of FGFR signaling in our experimental paradigm. Alternatively, FGFR-independent Hedgehog signaling mechanisms might maintain Hey1 and Hey2 expression in the absence of FGFR signaling. Further studies are needed to determine the mechanisms of FGFR-dependent regulation of Hey1 and Hey2 expression in prosensory cells.
Discussion
Hey1 and Hey2 prevent premature Atoh1 upregulation in prosensory cells Hey1 and Hey2, which are highly expressed in prosensory cells in the developing cochlea, have been recently implicated in prosensory cell specification downstream of Notch signaling (Hayashi et al., 2008b) . However, our loss-of-function data suggest that Hey1 and Hey2 are dispensable for prosensory domain specification but are critical components of the molecular machinery that negatively controls the graded upregulation of Atoh1 in HC precursors during cochlear differentiation. In the murine cochlea, Atoh1 promoter activity can be detected in prosensory cells as early as E12.5 (Woods et al., 2004; Yang et al., 2010; Driver et al., 2013) . In contrast, Atoh1 transcript and protein levels are exceedingly low at this stage. Starting at E13.5-E14.0, Atoh1 transcript and protein are rapidly induced in nascent HCs following the basal-to-apical and medial-to-lateral gradient of HC differentiation, suggesting the existence of a regulatory mechanism that negatively regulates the graded upregulation of Atoh1 in HC precursors (Chen et al., 2002b; . Our expression and functional data identify Hey1 and Hey2 as an integral part of this negative regulatory mechanism. We show that Hey1 and Hey2 downregulation occurs independently of Atoh1, indicating that Hey1 and Hey2 act upstream of Atoh1 in the differentiating cochlea. Moreover, we demonstrate that genetic inactivation of Hey1 and Hey2 results in premature upregulation of Atoh1 transcript and Atoh1 enhancer activity (Atoh1/nGFP) in IHC and OHC precursors. Similarly, a decrease in expression of Hey1 and Hey2 due to loss of Hedgehog signaling results in premature induction of HC-specific Atoh1/nGFP in the developing cochlea, whereas an increase in Hey1 and Hey2 expression due to overactivation of Hedgehog signaling delays HC-specific Atoh1/nGFP expression. How do HEY1 and HEY2 inhibit Atoh1 expression? It is likely that HEY1 and HEY2 interfere with the ability of ATOH1 to auto-regulate its own expression. Such interference could take place on a posttranscriptional level, as both HEY1 and HEY2 are known to bind to ATOH1, which would render ATOH1 inactive (Sakamoto et al., 2003; Doetzlhofer et al., 2009 ). In addition, HEY1 and HEY2 could bind to Hey binding motifs present in the Atoh1 auto-regulatory enhancer element and interfere with Atoh1 auto-regulation on a transcriptional level (Helms et al., 2000; Lumpkin et al., 2003; Heisig et al., 2012) .
Hey1 and Hey2 are not required for maintaining prosensory cell proliferation In the developing brain, HES/HEY factors are critical for maintaining neuronal stem cells/progenitor cells in the cell cycle, and their continued expression prevents premature differentiation (Sakamoto et al., 2003; Kageyama et al., 2008) . In contrast to the dual role of HEY1 and HEY2 in neuronal stem cell/progenitor cell proliferation and differentiation, our data indicate that loss of Hey1 and Hey2 only affects HC and SC differentiation without altering prosensory cell proliferation or cell cycle withdrawal. Interestingly, a recent study by Murata et al. (2009) revealed that HES1, which is broadly expressed in the developing cochlear epithelium before differentiation, is critical for prosensory cell proliferation, and loss of Hes1 results in premature cell cycle withdrawal of prosensory cells. However, loss of Hes1 does not alter the timing of HC and SC differentiation. These findings suggest that, in the developing cochlea, HES1 and HEY1/HEY2 play divergent roles at the prosensory stage, with HES1 being required for keeping prosensory cells proliferating and HEY1/HEY2 being required for maintaining prosensory cells undifferentiated.
Hey1 and Hey2 are required for proper HC and SC patterning
Previous work demonstrated that HEY1 and HEY2, in cooperation with HES1 and HES5, play a central role in patterning the auditory sensory epithelium Tateya et al., 2011) . In contrast to Hes/Hey compound mutants in which both HC density and the total number of HCs are significantly increased Tateya et al., 2011) , the total number of HCs is not significantly changed in the absence of Hey1 and Hey2. Instead, OHCs and oSCs are unevenly distributed along the cochlear duct, with ectopic OHCs and ectopic oSCs being frequently found in the cochlear base and OHCs and oSCs are frequently missing in the cochlear apex. Our analysis did not reveal any defects in the prosensory cell formation, proliferation, or cell cycle withdrawal in the absence of Hey1 and Hey2, suggesting that this unique defect in OHC patterning arises during cellular differentiation. In parallel with cellular differentiation, the auditory sensory epithelium undergoes dramatic changes in both width and length. Convergence and extension (CE) under the control of the planar cell polarity (PCP) pathway ) is thought to drive these changes. In CE/PCP mutants, HCs are misaligned, HC bundles are misoriented, and the number of OHC rows varies (Etheridge et al., 2008; Narimatsu et al., 2009) . It is plausible that the premature onset of HC differentiation in the absence of Hey1 and Hey2 alters or disrupts CE of the auditory sensory epithelium. Alternatively, loss of Hey1 and Hey2 might deregulate genes directly or indirectly involved in CE/PCP. Future studies will have to determine whether and how the CE/PCP pathway is affected in Hey1-Hey2 double-mutant cochlea. The continued expression of Hey1 and Hey2 in a subset of SC precursors and, later, in outer short arrow indicates medial-to-lateral gradient. I, Quantification of basal-to-apical extent of HC-specific Atoh1/nGFP expression in DMSO (dark gray bar), SHH ϩ DMSO (purple bar), SU5402 (light gray bar), and SHH ϩ SU5402 (white bar). Error bars indicate mean Ϯ SEM (n ϭ 5). *p Յ 0.05. n.s., Not significant. J, FGFR signaling is required for SHH-mediated activation of Hey1 and Hey2 transcription. Shown is qPCR-based analysis of Hey1 and Hey2 mRNA levels in control (dark gray bar), SHH (purple bar), SU5402 (light gray bar), and SHH ϩ SU5402 (white bar) treated cochlear epithelia after a 24 h treatment. Scale bar, 200 m. Errors bars indicate mean Ϯ SEM (n ϭ 3, two independent experiments). *p Յ 0.05. n.s., Not significant.
